Clinical Trials Directory

Trials / Completed

CompletedNCT05327660

CO Monitoring for Tobacco Cessation in Quitlines

Remote Carbon Monoxide Monitoring and Incentives for Tobacco Cessation in Quitlines

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
229 (actual)
Sponsor
Consumer Wellness Solutions · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The present study is a 3-arm randomized controlled pilot study. Participants who call the Maryland Tobacco Quitline and are eligible for study participation are randomized to receive quitline tobacco cessation treatment as usual (TAU), TAU plus remote carbon monoxide (CO) monitoring via smartphone app, or TAU plus remote carbon monoxide monitoring plus incentives vis smartphone app. The investigators hypothesize that remote CO monitoring will be feasible and acceptable to deliver in the quitline setting, will increase treatment engagement, and will increase tobacco cessation and treatment satisfaction rates.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTQuitline Treatment as Usual (TAU)Quitline TAU is services provided by the state quitline and includes phone coaching, nicotine replacement, supplemental materials (e.g., text messaging, online content).
COMBINATION_PRODUCTRemote Carbon Monoxide (CO) MonitoringRemote CO monitoring includes a smartphone app and a remote carbon monoxide monitor. The app tracks and prompts daily use of the CO monitor.
COMBINATION_PRODUCTIncentivized Remote CO MonitoringIncentivized remote CO monitoring includes a smartphone app and a remote carbon monoxide monitor. The app tracks and prompts daily use of the CO monitor and delivers small monetary incentives for each use of the CO monitor.

Timeline

Start date
2021-12-31
Primary completion
2022-11-01
Completion
2022-11-01
First posted
2022-04-14
Last updated
2024-10-28
Results posted
2024-10-28

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05327660. Inclusion in this directory is not an endorsement.